General information about company
Scrip Code*	524654
NSE Symbol	NA
MSEI Symbol	NA
ISIN	INE936B01015
Name of the listed entity	Natural Capsules Limited

Statement(1)
Mode of Fund Raising	Rights Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds	06-01-2022
Amount Raised (in Rs. Crores)	7.79
Report filed for Quarter ended	31-12-2023
Monitoring Agency	Not applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review	No
Comments of the auditors, if any

Sr.	Original Object	Modified Object, if any	Original Allocation	Modified allocation, if any	Funds Utilised	Amount of Deviation/Variation for the quarter according to applicable object	Remarks if any
1	Meeting Capital Expenditure for Modernization/Expansion of Capsules Unit and Investment in Subsidiary viz, Natural Biogenex Private Limited	0	77908750	0	77908750	0

Statement(2)
Mode of Fund Raising	Rights Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds	14-07-2022
Amount Raised (in Rs. Crores)	7.08
Report filed for Quarter ended	31-12-2023
Monitoring Agency	Not applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review	No
Comments of the auditors, if any

Sr.	Original Object	Modified Object, if any	Original Allocation	Modified allocation, if any	Funds Utilised	Amount of Deviation/Variation for the quarter according to applicable object	Remarks if any
1	Meeting Capital Expenditure for Modernization/Expansion of Capsules Unit and Investment in Subsidiary viz, Natural Biogenex Private Limited	0	70801900	0	70801900	0

Statement(3)
Mode of Fund Raising	Rights Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds	01-10-2022
Amount Raised (in Rs. Crores)	0.44
Report filed for Quarter ended	31-12-2023
Monitoring Agency	Not applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review	No
Comments of the auditors, if any

Sr.	Original Object	Modified Object, if any	Original Allocation	Modified allocation, if any	Funds Utilised	Amount of Deviation/Variation for the quarter according to applicable object	Remarks if any
1	Meeting Capital Expenditure for Modernization/Expansion of Capsules Unit and Investment in Subsidiary viz, Natural Biogenex Private Limited	0	4402908.64	0	4402908.64	0

Statement(4)
Mode of Fund Raising	Rights Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds	12-01-2023
Amount Raised (in Rs. Crores)	14.63
Report filed for Quarter ended	31-12-2023
Monitoring Agency	Not applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review	No
Comments of the auditors, if any

Sr.	Original Object	Modified Object, if any	Original Allocation	Modified allocation, if any	Funds Utilised	Amount of Deviation/Variation for the quarter according to applicable object	Remarks if any
1	Meeting Capital Expenditure for Modernization/Expansion of Capsules Unit and Investment in Subsidiary viz, Natural Biogenex Private Limited	0	146393300	0	146393300	0

Statement(5)
Mode of Fund Raising	Rights Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds	06-03-2023
Amount Raised (in Rs. Crores)	0.29
Report filed for Quarter ended	31-12-2023
Monitoring Agency	Not applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review	No
Comments of the auditors, if any

Sr.	Original Object	Modified Object, if any	Original Allocation	Modified allocation, if any	Funds Utilised	Amount of Deviation/Variation for the quarter according to applicable object	Remarks if any
1	Meeting Capital Expenditure for Modernization/Expansion of Capsules Unit and Investment in Subsidiary viz, Natural Biogenex Private Limited	0	2870680	0	2870680	0

Statement(6)
Mode of Fund Raising	Rights Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds	14-07-2023
Amount Raised (in Rs. Crores)	0.044
Report filed for Quarter ended	31-12-2023
Monitoring Agency	Not applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review	No
Comments of the auditors, if any

Sr.	Original Object	Modified Object, if any	Original Allocation	Modified allocation, if any	Funds Utilised	Amount of Deviation/Variation for the quarter according to applicable object	Remarks if any
1	Meeting Capital Expenditure for Modernization/Expansion of Capsules Unit and Investment in Subsidiary viz, Natural Biogenex Private Limited	0	447433.5	0	447433.5	0

Statement(7)
Mode of Fund Raising	Rights Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds	30-10-2023
Amount Raised (in Rs. Crores)	0.34
Report filed for Quarter ended	31-12-2023
Monitoring Agency	Not applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review	No
Comments of the auditors, if any

Sr.	Original Object	Modified Object, if any	Original Allocation	Modified allocation, if any	Funds Utilised	Amount of Deviation/Variation for the quarter according to applicable object	Remarks if any
1	Meeting Capital Expenditure for Modernization/Expansion of Capsules Unit and Investment in Subsidiary viz, Natural Biogenex Private Limited	0	3352140	0	3341080.33	0

Signatory Details
Name of signatory	Shilpa Burman
Designation of person	Company Secretary and Compliance Officer
Place	Bangalore
Date	09-02-2024